Skip to main content
Clinical Trials/NCT05199454
NCT05199454
Recruiting
Not Applicable

Role of Adiposomes in Diabetes-Associated Endothelial Dysfunction and Restorative Effects of Exercise and Metabolic Surgery

University of Illinois at Chicago1 site in 1 country60 target enrollmentMay 16, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
University of Illinois at Chicago
Enrollment
60
Locations
1
Primary Endpoint
Brachial artery flow-mediated dilation (percent vasodilation) in 60 obese diabetic subjects
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The development of type II diabetes (T2D) is strongly associated with obesity and both are well-established risk factors for cardiovascular disease. Knowing that vascular dysfunction is an early event in the development of cardiovascular disease in obese diabetic (OB-T2D) patients, The investigators set their long-term goal to define molecular mechanisms of vascular dysfunction and corrective strategies that target these mechanisms such as physical activity and weight loss. The investigators recently discovered that human adipose tissues release extracellular vesicles (adiposomes) that are efficiently captured by endothelial cells. Adiposomes are known to carry bioactive cargos such as proteins and micro RNAs; however, their lipid content has not been studied nor has their ability to transfer their lipid cargo to endothelial cells. In the current application, the investigators propose to investigate the role of adiposomes in communicating the unhealthy milieu, mainly dysregulated lipids, to endothelial cells in OB-T2D subjects. On top of these lipid species that the investigators propose to be carried by adiposomes are glycosphingolipids (GSLs). These lipids originate from the glycosylation of ceramides, a chemical process that is upregulated in the presence of inflammation and high glucose levels. Preliminary findings showed that in endothelial cells, GSL-rich adiposomes disturb plasma membrane structure and subsequently induce endothelial dysfunction. Moreover, the investigators found that preconditioning endothelial cells with high shear stress (which is an exercise mimetic) protected endothelial cells from the detrimental effects induced by adiposomes. Therefore, the central hypothesis is that adipose tissues in OB-T2D patients release GSL-loaded adiposomes that induce vascular endothelial dysfunction. The researchers propose that exercise and weight loss interventions (bariatric surgery) will restore adipose tissue homeostasis, reduce GSL-loaded adiposomes, and subsequently alleviate vascular risk in OB-T2D patients. The investigators will test the hypotheses by pursuing the following aims: aim 1: Investigate the role of GSL-rich adiposomes in the pathogenesis of endothelial dysfunction in OB-T2D adults; aim 2: Test the effectiveness of exercise training in reducing adiposome-mediated effects on vascular function; and aim 3: Examine changes in adiposome/caveolae axis following metabolic surgery and their association with vascular function.

Registry
clinicaltrials.gov
Start Date
May 16, 2022
End Date
December 31, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Abeer M. Mohamed

Assistant Professor

University of Illinois at Chicago

Eligibility Criteria

Inclusion Criteria

  • BMI ≥ 35 kg/m2
  • Between ages 18-50 years
  • Not pregnant
  • Diabetic (Current use of diabetes medication or fasting glucose ≥126 mg/dL)
  • Medical clearance to participate in a moderate-intensity exercise program

Exclusion Criteria

  • Pregnant women
  • Current smokers
  • Currently abusing alcohol or drugs
  • Chronic heart, liver, or kidney diseases, autoimmune diseases, or cancer
  • Non-English speakers
  • History of allergic reactions to lidocaine

Outcomes

Primary Outcomes

Brachial artery flow-mediated dilation (percent vasodilation) in 60 obese diabetic subjects

Time Frame: 4 years

Brachial flow-mediated dilation will be measured using ultrasound Alpha 7. For recording, a linear probe will be positioned five centimeters above the left arm's antecubital fossa, and a 1-minute baseline imaging will be recorded. Then, a blood pressure cuff will be put around the right mid-forearm and inflated to 200 to 220 mmHg for 5 minutes. Following cuff deflation (reactive hyperemia), a video grabber will be used to record a 300-second video sequence at three frames per second for offline measurement. The greatest brachial artery diameter at baseline will be deducted from the largest mean values obtained following cuff deflation to determine relative flow mediated dilation

Secondary Outcomes

  • Glycosphingolipid content (ng/ml) in adiposomes from 60 obese diabetic subjects(4 years)

Study Sites (1)

Loading locations...

Similar Trials